베인은 홈페이지 기능 및 성능 개선을 위해 쿠키를 사용합니다. 이와 관련된 더 많은 정보는 개인정보 메뉴에서 확인하실 수 있습니다. 이 웹사이트를 계속 사용하시면 쿠키 사용에 동의하신 것으로 간주됩니다. 

MedTech Dive

Medtechs adapt to new sales reality amid halt on elective surgeries, hospitals' financial stress

Medtechs adapt to new sales reality amid halt on elective surgeries, hospitals' financial stress

One by one, medtech companies have warned investors that a temporary pause on elective procedures — the bread and butter for many device maker and hospital balance sheets alike — render best-laid 2020 forecasts obsolete.

  • 2020년4월9일
  • 읽기 소요시간

MedTech Dive

Medtechs adapt to new sales reality amid halt on elective surgeries, hospitals' financial stress

Ultimately, COVID-19 could change the "one-dimensional" nature of medtech sales, he said.  

That reorientation could be especially important, given that the pandemic may prompt hospitals to rethink infection prevention protocols and potential restrictions to sales rep access beyond the current moment, said Tim van Biesen, who heads Bain & Company's global healthcare practice.

"If there's no going back to normal, then what's the what's the new normal?" van Biesen said that question "raises the opportunity for manufacturers to now get ahead of that from a technological standpoint."

MedTech Dive